![]() ![]() | Generic Calan (Verapamil)Blood Pressure Drug, Cardiovascular Drug | ||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Most popular quantity. Information About Generic Calan (Verapamil)What is Generic Calan (Verapamil)Working of Generic Calan (Verapamil)Generic Calan (Verapamil) Dosage or AdministrationPrecautions for Taking Generic Calan (Verapamil)Interaction of Generic Calan (Verapamil) with Other DrugsSide effects of Generic Calan (Verapamil)
Verapamil is generic equivalent of Calan, it is used for Treatment of vasospastic (Prinzmetal's variant), chronic stable (classic effort-associated), and unstable (crescendo, preinfarction) angina; adjunctive treatment with digitalis to control ventricular rate at rest and during stress in atrial flutter or fibrillation; prophylaxis of repetitive paroxysmal supraventricular tachycardia (PSVT); management of essential hypertension. Sustained-release: Management of essential hypertension. Parenteral: Rapid conversion of PSVTs to sinus rhythm; temporary control of rapid ventricular rate in atrial flutter or fibrillation. Treatment of migraine and cluster headaches; treatment of hypertrophic cardiomyopathy. What is Generic Calan (Verapamil)Generic Calan belong to calss Calcium channel blocker. Generic Calan Inhibits movement of calcium ions across cell membrane resulting in depression of mechanical contraction of myocardial and vascular smooth muscle and depression of impulse formation (automaticity) and conduction velocity. Generic Calan (Verapamil) Dosage or AdministrationADULTS: PO 40 to 160 mg tid. Do not exceed 480 mg/day. Sustained release: PO 120 to 480 mg/day. Lower doses are given once daily; larger doses divided into 2 doses. ADULTS: IV 5 to 10 mg bolus over 2 min. May repeat with 10 mg, 30 min after first dose. Give slower (over at least 3 min) in older patients. CHILDREN 1 to 15 yr: IV 0.1 to 0.3 mg/kg (not to exceed 5 mg) over at least 2 min. May repeat in 30 min. CHILDREN less than 1 yr: IV 0.1 to 0.2 mg/kg (usual range, 0.75 to 2 mg) bolus
over 2 min with continuous ECG monitoring. Precautions for Taking Generic Calan (Verapamil)Pregnancy: Category C. Lactation: Excreted in breast milk. CHILDREN: Children less than 6 mo may not respond to IV use. Rare severe hemodynamic side effects have occurred in newborns and infants after IV use. ELDERLY: May have greater hypotensive effects in elderly. Elderly may respond to lower doses. Antiplatelet effects: Calcium channel blockers may inhibit platelet function. Cardiac conduction: May be associated with variety of cardiac conduction abnormalities including first-, second-, or third-degree AV block; bradycardia; asystole; severe hypotension; nodal escape rhythms; PR prolongation; and ventricular tachycardia in patients with atrial flutter/fibrillation and W-P-W syndrome caused by antegrade conduction. Interaction of Generic Calan (Verapamil) with Other DrugsOther antihypertensive agents: Additive hypotension. Beta blockers: May result in increased hypotension and adverse effects because of additive depressant effects on myocardial contractility or AV conduction. Buspirone: Pharmacologic and adverse effects may be increased by verapamil. Calcium salts: Clinical effects and toxicities of verapamil may be reversed. Carbamazepine: Increased carbamazepine serum levels. Cyclosporine: Increased cyclosporine levels may result. Dofetilide: Risk of life-threatening ventricular arrhythmias, including torsades de pointes, may be increased. Coadministration with verapamil is contraindicated. Digitalis glycosides: Increased serum digoxin or digitoxin levels may occur. Disopyramide: Do not use 48 hr before or 24 hr after verapamil. Flecainide: May prolong AV conduction. Nondepolarizing muscle relaxants: Enhanced muscle relaxant effects and prolonged respiratory depression may occur. Prazosin: Increased prazosin serum levels may result. Quinidine: Hypotension, bradycardia, ventricular tachycardia, AV block, and pulmonary edema may occur. Rifampin: Loss of effectiveness of oral verapamil may occur. IV Simvastatin: Plasma levels may be elevated by verapamil, increasing the risk of toxicity (eg, rhabdomyolysis). Side effects of Generic Calan (Verapamil)CARDIOVASCULAR: Peripheral edema; hypotension; AV block; bradycardia; CHF;
pulmonary edema; cerebrovascular accident. CNS: Dizziness; lightheadedness;
headache; asthenia. DERMATOLOGIC: Dermatitis; rash; sweating; gingival hyperplasia.
GI: Nausea; constipation. HEPATIC: Increased transaminases; hepatitis. RESPIRATORY:
Shortness of breath; dyspnea; wheezing. | |||||||||||||||||||||||||||||||||||||||||